NJT · Class I — Low Risk (general controls) · Hematology · 21 CFR 864.1860
Classification
FDA Product Code
NJT
Device class
Class I — Low Risk (general controls)
Regulation
21 CFR 864.1860
Review panel
PA
Medical specialty
Hematology
Submission type
4
GMP exempt
N
Life sustaining
N
Implant
N
Third-party review
N
Definition
according to the regs..."..used after the primary diagnosis of tumor (neoplasm) has been made by conventional histopathology using nonimmunologic histochemical stains, such as hematoxylin and eosin.